|
Name |
14-Hydroxydihydromelleolide
|
Molecular Formula | C23H30O7 | |
IUPAC Name* |
[(2R,2aS,4aS,6S,7bR)-2a-hydroxy-3,6-bis(hydroxymethyl)-6,7b-dimethyl-1,2,4a,5,7,7a-hexahydrocyclobuta[e]inden-2-yl] 2,4-dihydroxy-6-methylbenzoate
|
|
SMILES |
CC1=CC(=CC(=C1C(=O)O[C@@H]2C[C@]3([C@@]2(C(=C[C@H]4C3C[C@@](C4)(C)CO)CO)O)C)O)O
|
|
InChI |
InChI=1S/C23H30O7/c1-12-4-15(26)6-17(27)19(12)20(28)30-18-9-22(3)16-8-21(2,11-25)7-13(16)5-14(10-24)23(18,22)29/h4-6,13,16,18,24-27,29H,7-11H2,1-3H3/t13-,16?,18-,21+,22-,23+/m1/s1
|
|
InChIKey |
HDGURVCSOJDUHT-GJQGFOMNSA-N
|
|
Synonyms |
14-Hydroxydihydromelleolide
|
|
CAS | NA | |
PubChem CID | 102068113 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 418.5 | ALogp: | 2.4 |
HBD: | 5 | HBA: | 7 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 127.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 30 | QED Weighted: | 0.376 |
Caco-2 Permeability: | -5.6 | MDCK Permeability: | 0.00000397 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.124 |
Human Intestinal Absorption (HIA): | 0.061 | 20% Bioavailability (F20%): | 0.959 |
30% Bioavailability (F30%): | 0.022 |
Blood-Brain-Barrier Penetration (BBB): | 0.131 | Plasma Protein Binding (PPB): | 85.58% |
Volume Distribution (VD): | 0.832 | Fu: | 14.36% |
CYP1A2-inhibitor: | 0.57 | CYP1A2-substrate: | 0.374 |
CYP2C19-inhibitor: | 0.065 | CYP2C19-substrate: | 0.355 |
CYP2C9-inhibitor: | 0.253 | CYP2C9-substrate: | 0.136 |
CYP2D6-inhibitor: | 0.172 | CYP2D6-substrate: | 0.087 |
CYP3A4-inhibitor: | 0.899 | CYP3A4-substrate: | 0.23 |
Clearance (CL): | 6.801 | Half-life (T1/2): | 0.833 |
hERG Blockers: | 0.034 | Human Hepatotoxicity (H-HT): | 0.337 |
Drug-inuced Liver Injury (DILI): | 0.945 | AMES Toxicity: | 0.13 |
Rat Oral Acute Toxicity: | 0.097 | Maximum Recommended Daily Dose: | 0.875 |
Skin Sensitization: | 0.355 | Carcinogencity: | 0.685 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.132 |
Respiratory Toxicity: | 0.18 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001937 | 0.505 | D08PIQ | 0.252 | ||||
ENC000887 | 0.495 | D07DVK | 0.248 | ||||
ENC003451 | 0.434 | D03BLF | 0.248 | ||||
ENC003450 | 0.434 | D03IKT | 0.248 | ||||
ENC002145 | 0.418 | D0CW1P | 0.248 | ||||
ENC003839 | 0.414 | D0F1EX | 0.248 | ||||
ENC003838 | 0.414 | D0IT2G | 0.248 | ||||
ENC003449 | 0.414 | D0D1SG | 0.246 | ||||
ENC002788 | 0.405 | D0E9KA | 0.244 | ||||
ENC002211 | 0.404 | D0I5DS | 0.242 |